TERM ID="NYU_TERM_1" STRING="BP" FREQUENCY=3 START=370 END=372 LEMMA="BP" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_2" STRING="BP" FREQUENCY=3 START=695 END=697 LEMMA="BP" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="BP" FREQUENCY=3 START=775 END=777 LEMMA="BP" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="Bisphosphonates" FREQUENCY=3 START=353 END=368 LEMMA="BISPHOSPHONATE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="Bisphosphonates" FREQUENCY=3 START=0 END=15 LEMMA="BISPHOSPHONATE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_6" STRING="Bisphosphonates" FREQUENCY=3 START=353 END=368 LEMMA="BISPHOSPHONATE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="affinity" FREQUENCY=1 START=763 END=771 LEMMA="AFFINITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="affinity of BP" FREQUENCY=1 START=763 END=777 LEMMA="BP AFFINITY" LEMMA_FREQUENCY=1 HEAD_TERM="affinity" HEAD_LEMMA="AFFINITY"
TERM ID="NYU_TERM_9" STRING="anti-atherogenic activity" FREQUENCY=1 START=666 END=691 LEMMA="ANTI-ATHEROGENIC ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="anti-atherogenic activity of BP" FREQUENCY=1 START=666 END=697 LEMMA="BP ANTI-ATHEROGENIC ACTIVITY" LEMMA_FREQUENCY=1 HEAD_TERM="anti-atherogenic activity" HEAD_LEMMA="ANTI-ATHEROGENIC ACTIVITY"
TERM ID="NYU_TERM_11" STRING="atherosclerotic process" FREQUENCY=1 START=462 END=485 LEMMA="ATHEROSCLEROTIC PROCESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="biological linkage" FREQUENCY=1 START=157 END=175 LEMMA="BIOLOGICAL LINKAGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="bone resorption" FREQUENCY=1 START=381 END=396 LEMMA="BONE RESORPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="cardiovascular disease" FREQUENCY=1 START=90 END=112 LEMMA="CARDIOVASCULAR DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="cholesterol synthesis" FREQUENCY=1 START=553 END=574 LEMMA="CHOLESTEROL SYNTHESIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="clinical settings" FREQUENCY=1 START=116 END=133 LEMMA="CLINICAL SETTING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="concentration" FREQUENCY=1 START=850 END=863 LEMMA="CONCENTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="dual-purpose therapies" FREQUENCY=1 START=263 END=285 LEMMA="DUAL-PURPOSE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="enhancing bone density" FREQUENCY=1 START=300 END=322 LEMMA="ENHANCING BONE DENSITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="fracture risk" FREQUENCY=1 START=401 END=414 LEMMA="FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="inflammatory progression" FREQUENCY=1 START=576 END=600 LEMMA="INFLAMMATORY PROGRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="interference" FREQUENCY=1 START=535 END=547 LEMMA="INTERFERENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="osteoporosis" FREQUENCY=1 START=73 END=85 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="oxidative stress" FREQUENCY=1 START=606 END=622 LEMMA="OXIDATIVE STRESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="pharmacological effect" FREQUENCY=1 START=890 END=912 LEMMA="PHARMACOLOGICAL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="reducing atherosclerosis" FREQUENCY=1 START=327 END=351 LEMMA="REDUCING ATHEROSCLEROSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="vascular calcification" FREQUENCY=1 START=193 END=215 LEMMA="VASCULAR CALCIFICATION" LEMMA_FREQUENCY=1
